Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2025-12-24 @ 1:33 PM
NCT ID:
NCT05174195
Eligibility Criteria:
Inclusion criteria:
* Women age of 18 - 42 years
* Interested in the use of ESI
* Accepting to have 90 days pre-treatment with OD
* Signed informed consent
Exclusion criteria:
* Pregnancy
* Lactation,
* vaginal bleeding of unknown origin,
* wish to become pregnant,
* weight over 80 kg,
* history of deep vein thrombosis/Pulmanory embolism,
* hypertension,
* Diabetes or other metabolic diseases,
* coagulation disorders,
* severe hepatic disorder,
* history of breast/endometrial cancer,
* known hypersensitivity to study drug,
* current treatment with enzyme inducing drugs (e.g.: phenytoin, carbamazepine, phenobarbital, etc.)
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
42 Years
Study:
NCT05174195
Study Brief:
Protocol Section:
NCT05174195